申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:EP3656769A1
公开(公告)日:2020-05-27
Disclosed is a class of new aryl-phosphorus-oxygen compounds as shown in formula (I) as EGFR kinase inhibitors, and pharmaceutically acceptable salts thereof.
公开了一类如式(I)所示的作为表皮生长因子受体激酶抑制剂的新型芳基磷氧化合物及其药学上可接受的盐类。